The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β

被引:43
作者
Bannerman, DD
Tupper, JC
Kelly, JD
Winn, RK
Harlan, JM
机构
[1] Univ Washington, Div Hematol, Sch Med, Dept Surg, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Sch Med, Seattle, WA 98104 USA
[3] Zymogenet Inc, Seattle, WA 98105 USA
关键词
D O I
10.1172/JCI14774
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Activation of NF-kappaB by bacterial LPS promotes the upregulation of proinflammatory cytokines that contribute to the pathogenesis of Gram-negative septic shock. LPS activation of NF-kappaB is dependent upon the interaction of two death domain-containing (DD-containing) proteins, MyD88 and IL-1 receptor-associated kinase IRAK. Another DD-containing protein, Fas-associated death domain (FADD), also binds MyD88 through respective D-DD interactions. Although FADD has been classically described as a proapoptotic signaling molecule, several reports have implicated a role for FADD in mediating NF-kappaB activation. In the present report, we investigated whether FADD could mediate LPS activation of NF-kappaB. Overexpression of FADD blocked LPS-induced NF-kappaB activation, whereas absence of FADD enhanced activation of NF-kappaB by LPS. Further, LPS-induced expression of two NF-kappaB-dependent gene products, IL-6 and KC, was enhanced in FADD(-/-) mouse embryo fibroblasts (MEFs) compared with wild-type. This increase in NF-kappaB activity correlated with enhanced IkappaB degradation. FADD(-/-) MEFs were also resistant to NF-kappa,B activation induced by IL-1 P. Finally, reconstitution of full-length FADD in the FADD(-/-) MEFs completely reversed the enhanced activation of NF-kappaB elicited by either LPS or IL-1beta. Together, these data indicate that FADD negatively regulates LPS- and IL-1beta-induced NF-kappaB activation and that this regulation occurs upstream of IkappaB degradation.
引用
收藏
页码:419 / 425
页数:7
相关论文
共 35 条
  • [21] A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death
    Ouaaz, F
    Li, M
    Beg, AA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) : 999 - 1004
  • [22] Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells
    Pahan, K
    Raymond, JR
    Singh, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) : 7528 - 7536
  • [23] Trends in infectious diseases mortality in the United States
    Pinner, RW
    Teutsch, SM
    Simonsen, L
    Klug, LA
    Graber, JM
    Clarke, MJ
    Berkelman, RL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03): : 189 - 193
  • [24] RYSECK RP, 1991, ONCOGENE, V6, P533
  • [25] Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells
    Schaub, FJ
    Han, DKM
    Liles, WC
    Adams, LD
    Coats, SA
    Ramachandran, RK
    Seifert, RA
    Schwartz, SM
    Bowen-Pope, DF
    [J]. NATURE MEDICINE, 2000, 6 (07) : 790 - 796
  • [26] Sizemore N, 1999, MOL CELL BIOL, V19, P4798
  • [27] I-KAPPA-B-BETA REGULATES THE PERSISTENT RESPONSE IN A BIPHASIC ACTIVATION OF NF-KAPPA-B
    THOMPSON, JE
    PHILLIPS, RJ
    ERDJUMENTBROMAGE, H
    TEMPST, P
    GHOSH, S
    [J]. CELL, 1995, 80 (04) : 573 - 582
  • [28] RECEPTOR-DEPENDENT MECHANISMS OF CELL STIMULATION BY BACTERIAL-ENDOTOXIN
    ULEVITCH, RJ
    TOBIAS, PS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 437 - 457
  • [29] Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6
    Vanden Berghe, W
    Vermeulen, L
    De Wilde, G
    De Bosscher, K
    Boone, E
    Haegeman, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1185 - 1195
  • [30] Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD)
    Wajant, H
    Haas, E
    Schwenzer, R
    Mühlenbeck, F
    Kreuz, S
    Schubert, G
    Grell, M
    Smith, C
    Scheurich, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24357 - 24366